Therapeutic Action
Antihypertensive vasodilator (calcium channel blocker)
PDF page 35
Loading InternPractice…
Drug reference
Antihypertensive vasodilator (calcium channel blocker)
PDF page 35
Hypertension
PDF page 35
Do not administer to patients with severe hypotension, shock, unstable heart failure after acute myocardial infarction. May cause: headache, dizziness, sensation of flushing or warmth, fatigue, ankle oedema (common at the start of treatment); hypotension, palpitations, abdominal pain, nausea, gingival hyperplasia. Administer with caution and monitor use with: other antihypertensive drugs (risk of hypotension); drugs with hypotensive effects (e.g. haloperidol, amitriptyline); fluconazole, erythromycin, fluoxetine, ritonavir (effects of amlodipine increased, particularly the antihypertensive effect); rifampicin, phenytoin, phenobarbital, carbamazepine (effects of amlodipine decreased). Pregnancy: no contra-indication. For the management of hypertension in pregnancy, use labetalol. Breast-feeding: avoid
PDF pages 35, 36
5 mg tablet
PDF page 35
Adult: 5 mg once daily. Increase to 10 mg once daily if necessary (max. 10 mg daily). In older patients or patients with hepatic impairment, start with 2.5 mg once daily then increase gradually if necessary.
PDF page 35
According to clinical response.
PDF page 35
Also comes in telmisartan 40 mg/amlopidine 5 mg coformulated tablet.
PDF page 36
– – Below 25 °C
PDF page 36
5 mg once daily. Increase to 10 mg once daily if necessary (max. 10 mg daily).
PDF page 35